Preclinical Services
July 2012 Preclinical Services Newsletter
Quick Links


Skeletal Muscle Evaluation in Sarcopenia and Cachexia Research

Accelerate Biosimilar Development


Ocular Research Resources

Site At-a-Glance

Webinars

Podcasts

Posters

Courses & Seminars
SitePreclinical Site At-a-Glance 

 

Reno, Nevada
Rene Remie courses  

For two decades, Charles River has been supporting West Coast biotechnology and pharmaceutical drug development needs at our facility in Reno, Nevada. This sustainable, state-of-the-art facility is a multi-species, full-service laboratory that offers housing compliant with EU standards in most species. Our resident expert scientists have in-depth knowledge of biologics and small molecule development, as well as supporting services including dose formulation analysis, anatomic and clinical pathology, immunology (multiplex flow cytometry, Luminex and MSD technologies) and immunochemistry.

 

Click here to contact our Reno facility.

webinarArchived Webinars

JET with Blood Pressure

 

Vaccine Development Webinar Series

podcast

Podcasts 

 

Evaluation of MucilAir as an In Vitro Model of Human Airway Epithelium
 
posterPosters

Measurements of Growth in Rodent Juvenile Toxicology Studies 

Comparison of the Effect of STZ-Induced Diabetic Retinopathy on the Early ERG of Sprague Dawley and Long Evans Rats

Uterotrophic Assay in Ovariectomized Female Rats

 

Hershberger Assay in Castrated, Peripubertal Male Rats
CoursesUpcoming Courses & Seminars

18th Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development
September 10-12, 2012
Napa, California
Charles River Laboratories International, Incorporated
251 Ballardvale St.
Wilmington, MA 01887
 
mypreclinical

Rene Remie courses

mypreclinical, Your Global Portal to Preclinical Study Management

 

Our new and improved global portal, mypreclinical, offers customizable solutions and increased functionality for secure study tracking. Now available at all of our preclinical facilities. Learn more.

skeletal

Charles River Employs Skeletal Muscle Evaluation in Sarcopenia and Cachexia Research

 

Declining skeletal muscle associated with age-related and disuse sarcopenia and cancer cachexia represent important health problems that affect quality of life of patients with debilitating disease. Recent understanding of skeletal muscle pathways has led to the development of specific compounds to potentially prevent or treat sarcopenia/cachexia. Learn more.

biosimilar

Expert Testing to Accelerate Your Biosimilar Development

 

Charles River's experience with biologics and our broad portfolio of services uniquely position us as an ideal partner in the development and commercialization of biosimilars.  We provide the full spectrum of services needed to test and characterize biologics as well as the services needed to demonstrate biosimilarity.

Learn more

cites

Charles River & CITES: Refined Shipping Process to Expedite Timelines

 

Since the Canadian government implemented changes to its wildlife import/export permit system in 2010, Charles River has adapted its own internal application process to expedite timelines.  Learn more

ocular

Ocular Research Resource Center

 

Charles River's unique customized approach to conducting ocular efficacy and toxicology studies is designed to support your ocular programs.  

 

Below are resources available to assist you in better planning your ocular research:

  

OCT Resources


Ocular Coherence Tomography (OCT): New Insights in Ocular Research

 

 

 

 

Specular Microscopy Resources
 

 

The SourceSM Ocular Resources
 
The resources listed below are available in The SourceSM. Please click here to register.
 
Poster: Use of Spectral-Domain Optical Coherence Tomography (SD-OCT) to Monitor Subretinal Administration in Animal Models
 
 

  

To incorporate these technologies into your ocular research, contact us at askcharlesriver@crl.com.